Giorgia Guglielmi
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
N-acyl lipids are important, overlooked molecules shaped by diet and gut microbes.
Fiber can influence how well bacteria from a fecal microbiota transplant successfully settle and grow in a person’s gut.
Region-specific microbial transplants may be safer and more effective than standard fecal microbiota transplants.
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
Tracking the oral microbiota can help identify ECC risk early and inform prevention strategies in children, even before visible signs of decay.
AceCel is a promising way to help manage obesity by targeting gut bacteria and metabolism together.
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.
Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.
